triumph 4 retatrutide just delivered the first top-line Phase 3 results for a triple agonist in obesity β and the findings from TRIUMPH-4 are strikingπ A summary slide of the
Description
Diabetes Rev

Prescription and plan

The albiglutide-treated group had a 3-point lower risk of MACE (0.78

Results should be interpreted with a qualified healthcare provider to understand what your genetic profile may mean for semaglutide tolerability, titration strategy, and monitoring priorities

Your PlexusDx provider will coordinate this gap and start tirzepatide at a conservative dose to ensure safety and tolerability during the transition
Always use a regulated, registered pharmacy to ensure you receive genuine, safe medication
